This consultation brought together a wide range of immunisation and disease experts, manufacturers, countries and implementers to discuss the GAVI Alliance’s new Vaccine Investment Strategy, for 2014-2019
Copyright UNICEF/2006/Tony Figueira
This consultation brought together a wide range of immunisation and disease experts, manufacturers, countries and implementers to discuss the GAVI Alliance’s new Vaccine Investment Strategy (VIS), for 2014-2019.
The VIS aims to provide the GAVI Board with the ability to understand and take decisions about which vaccines to financially support and assist countries to implement in the coming years. The results of the VIS will also facilitate planning by countries, industry and partners around future priorities.
This consultation represents only one of many consultations that will be conducted with countries, partners, CSO, industry and experts over the coming months, in advance of the final VIS going to the GAVI Board for decision in December 2013.
Aurelia Nguyen from the GAVI Secretariat provided an overview of the VIS process and then invited participants to discuss the set of criteria that are being proposed to assess and compare priorities for potential future GAVI support.
Numerous country representatives expressed their overall agreement with the broad set of criteria proposed, which include considerations of public health impact, costs, equity, ease of integration into national immunisation programmes and vaccine supply.
Many also expressed their enthusiasm to engage further through consultations, as the selection of vaccines begins to be narrowed using the criteria discussed with forum participants.